Shares of Health Care sector company Catalent moved -0.3% today, and are now trading at a price of $47.07. The large-cap stock's daily volume was 91,506 compared to its average volume of 2,624,947. The S&P 500 index returned a -0.0% performance.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The company is based in Somerset and has 17,800 full time employees. Its market capitalization is $8,485,403,136.
14 analysts are following Catalent and have set target prices ranging from $44.0 to $58.0 per share. On average, they have given the company a rating of hold. At today's prices, CTLT is trading -8.23% away from its average analyst target price of $51.29 per share.
Over the last year, CTLT shares have gone down by -46.0%, which represents a difference of -62.0% when compared to the S&P 500. The stock's 52 week high is $89.69 per share and its 52 week low is $31.45.
|Date Reported||Cash Flow from Operations ($ k)||Capital expenditures ($ k)||Free Cash Flow ($ k)||YoY Growth (%)|